Avon Lifesciences has informed that as per the terms of 10,50,00,00 Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment Committee of the Board of Directors of the Company at the meeting held on October 21, 2015, has upon receipt of balance of 75% consideration aggregating to Rs 5,20,00,00 has approved allotment of 2,00,000 Equity Shares upon conversion of equivalent number of warrants at an issue price of Rs 26 per share.
The above information is a part of company’s filings submitted to BSE.